Clinical Trials and Special Access

Shionogi & Co., Ltd. and its subsidiary companies, including Shionogi Canada Inc., are committed to developing safe and effective medicines and treatments for patients worldwide through clinical trials of unapproved medicinal products (investigational drugs). The clinical trials are designed to evaluate whether such investigational drugs are safe and effective for treating a specific disease or condition before seeking regulatory approval to market the drugs.

Shionogi encourages patients and their healthcare providers to learn more about Shionogi’s clinical trial programs here.

In addition, Shionogi & Co., Ltd. and its subsidiary companies, may be able to supply certain drugs to Canadian healthcare professionals outside of a clinical trial.

Healthcare professionals should contact Health Canada for more details on the Health Canada Special Access Program. 

Shionogi & Co., Ltd. and its subsidiary companies, do not guarantee they can or will approve to the supply of drugs pursuant to a Health Canada Special Access Authorization, as they must evaluate several factors such as the total amount of available drugs stocked.